Literature DB >> 1053273

Treatment of hyperthyroidism with a large initial dose of sodium iodide I 131.

A M Safa, P G Skillern.   

Abstract

A retrospective study was undertaken of 229 patients with hyperthyroidism due to Graves disease treated at the Cleveland Clinic with a large initial dose of sodium iodide I 131 (mean dose, 12.7 +/- 7.5 millicuries). The results indicate that a large initial dose is the most effective therapy for this disorder. Ninety percent of this group of patients required only one dose and recovered from hyperthyroidism within 12 weeks. Because we are convinced that there is no way to prevent the development of hypothyroidism in these patients, we have prescribed permanent thyroid hormone replacement after the hyperthyroidism has been controlled. In a mean five-year follow-up of 190 patients, 174 (91.5%) were still taking thyroid hormone.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1053273

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  10 in total

1.  Scarred atrophic thyroid after I-131 therapy for Graves' disease documented at autopsy.

Authors:  Wei-Jen Shih; Bonnie Mitchell; Jennifer C Schott
Journal:  J Natl Med Assoc       Date:  2002-10       Impact factor: 1.798

2.  The treatment of hyperthyroidism.

Authors:  G Crile
Journal:  World J Surg       Date:  1978-05       Impact factor: 3.352

Review 3.  Controversies in the management of Graves' disease in children.

Authors:  S A Rivkees
Journal:  J Endocrinol Invest       Date:  2016-05-06       Impact factor: 4.256

4.  Relationship between body mass index and external exposure in hyperthyroid patients treated with iodine-131.

Authors:  Ghazal Yazdanpanah; Mohammad Nematdar; Hoda Talebian; Ali Shabestani Monfared
Journal:  Am J Nucl Med Mol Imaging       Date:  2022-06-15

5.  Radioiodine-131 treatment of thyrotoxicosis: dose required for and some factors affecting the early induction of hypothyroidism.

Authors:  C C Alevizaki; M C Alevizaki-Harhalaki; D G Ikkos
Journal:  Eur J Nucl Med       Date:  1985

6.  The early development of transient and permanent hypothyroidism following radioiodine therapy for hyperthyroid Graves' disease.

Authors:  N R Peden; I R Hart
Journal:  Can Med Assoc J       Date:  1984-05-01       Impact factor: 8.262

7.  Functional results of radioiodine therapy with a 300-Gy absorbed dose in Graves' disease.

Authors:  U F Willemsen; P Knesewitsch; T Kreisig; C R Pickardt; C M Kirsch
Journal:  Eur J Nucl Med       Date:  1993-11

8.  Radioiodine I-131 for the therapy of graves' disease.

Authors:  Malik Mumtaz; Lim Shueh Lin; Khaw Chong Hui; Amir Sharifuddin Mohd Khir
Journal:  Malays J Med Sci       Date:  2009-01

9.  The occurrence of hypothyroidism following radioactive iodine treatment of toxic nodular goiter is related to the TSH level.

Authors:  H I Adamali; J Gibney; D O'Shea; M Casey; T J McKenna
Journal:  Ir J Med Sci       Date:  2007-07-14       Impact factor: 1.568

Review 10.  Pediatric Graves' disease: management in the post-propylthiouracil Era.

Authors:  Scott A Rivkees
Journal:  Int J Pediatr Endocrinol       Date:  2014-06-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.